The constitutive activation of the NF-κB pathway not only contributes to increased cell proliferation, but also to the apoptosis resistance of lymphoma cells in CTCL [32]. Here, NFKB1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.